Royalty Pharma said Tuesday that it has withdrawn its legal challenge to an Irish Takeover Panel ruling, meaning that its $8-billion bid to buy Elan lapsed. "In light of recent developments, we are Full story
**NEW** The complete list of FirstWord Dossier reports can be found at www.fwreports.com
FirstWord Dossier reports provide insight, analysis and the latest thinking on important trends and the most challenging issues affecting the pharmaceutical industry today. Highly-focused, relevant, up-to-date and actionable intelligence ... reports that deliver information vital for competitive advantage.